Friday, July 10, 2026
🇺🇸 FDA

pharma · Refractory Focal Onset Epilepsy · Early Parkinson’s Disease

Biohaven Bioscience Ireland

Biohaven Bioscience Ireland Limited

Biohaven Bioscience Ireland trial registry — 7 ClinicalTrials.gov studies with program phase, status, and indication context.

GB HQ
EMA registrant Type
Company details
Status
Public
HQ
GB
Programs
7
Drugs
8
Patents
0
All projects Drug pipeline News & analysis
Intelligence · Clinical Trials

Biohaven Bioscience Ireland clinical trials

Registry index of 7 ClinicalTrials.gov studies linked to Biohaven Bioscience Ireland programs — each row shows trial ID, program name, phase, status, and indication.

Biohaven Bioscience Ireland trial registry — 7 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

7 updates

Latest clinical program signals indexed for Biohaven Bioscience Ireland.

  1. BHV8000-301 — Phase 3

    Clinical update

  2. BHV7000-304 — Phase 3

    Clinical update

  3. BHV7000-303 — Phase 3

    Clinical update

  4. BHV7000-302 — Phase 2

    Clinical update

  5. BHV2100-112 — Phase 1

    Clinical update

  6. BHV-1300 — Phase 1

    Clinical update

  7. BHV-7000, BHV-7000 — Phase 2

    Clinical update

Trial registry

7 studies

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.